Status:
WITHDRAWN
Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
Ullevaal University Hospital
Conditions:
Hearing Loss
Mental Retardation
Eligibility:
All Genders
1+ years
Brief Summary
The aim of this study is to investigate short and long term consequences from early postnatal HCMV infection transmitted via human milk in very preterm infants (birth weight \< 1500 g or gestational a...
Detailed Description
Approximately 70 % of fertile women in Norway are seropositive for HCMV. In practically all seropositive women a reactivation of the HCMV occurs during late pregnancy and lactation. In 75 - 80 % of HC...
Eligibility Criteria
Inclusion
- Birth weight below 1,500 grams
- Written parental consent
- Infants receiving their own mothers milk
Exclusion
- Congenital malformations
- Critical illness with short life expectancy
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01151462
Start Date
August 1 2010
End Date
May 1 2013
Last Update
September 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0424